What is the protocol for a 1 milligram (mg) dexamethasone suppression test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Perform the 1 mg Dexamethasone Suppression Test

Administer 1 mg of dexamethasone orally between 11:00 PM and midnight, then measure serum cortisol at 8:00 AM the following morning, with normal suppression defined as cortisol <1.8 μg/dL (50 nmol/L). 1

Test Protocol

Timing and Administration

  • Give 1 mg dexamethasone orally between 11:00 PM and midnight (standard timing is 11 PM-midnight, though some protocols specify 2300-2400h) 1
  • Collect blood for serum cortisol measurement at 8:00 AM the following morning 1
  • The patient should take the medication at home and present for blood draw the next morning 1

Interpretation of Results

Normal Response:

  • Serum cortisol **<1.8 μg/dL (50 nmol/L)** effectively rules out Cushing's syndrome with >90% sensitivity 1, 2
  • This threshold provides the highest diagnostic accuracy according to current Endocrine Society guidelines 1

Abnormal Response:

  • Serum cortisol ≥1.8 μg/dL (≥50 nmol/L) suggests possible Cushing's syndrome and requires further evaluation 2
  • Serum cortisol >5.0 μg/dL (138 nmol/L) indicates overt autonomous cortisol secretion 2, 1

Critical Pitfalls to Avoid

Medication Interactions

  • CYP3A4 inducers (phenobarbital, carbamazepine, phenytoin, rifampin, St. John's wort) accelerate dexamethasone metabolism, causing false-positive results (failure to suppress despite no Cushing's) 1, 3, 2
  • CYP3A4 inhibitors (fluoxetine, cimetidine, diltiazem) slow dexamethasone metabolism, causing false-negative results (suppression despite Cushing's) 1, 3
  • Oral contraceptives and estrogen therapy increase cortisol-binding globulin, falsely elevating total cortisol measurements 2

Patient Factors

  • Malabsorption or rapid gut transit can cause inadequate dexamethasone absorption, leading to false-positive results 1
  • Pseudo-Cushing's states (depression, alcoholism, severe obesity, polycystic ovary syndrome) can cause mild hypercortisolism that mimics true Cushing's syndrome 2, 1

Improving Test Accuracy

  • Consider measuring dexamethasone levels concomitantly with cortisol to confirm adequate drug absorption and exclude false results from abnormal metabolism 1, 2
  • This is particularly useful when results are equivocal or when medication interactions are suspected 2

Important Limitations

Sensitivity in Mild Disease

  • The test has reduced sensitivity (as low as 18-41%) in patients with mild or cyclic Cushing's syndrome who may suppress normally despite having the disease 4
  • Patients with mild hypercortisolism often suppress to values <5 μg/dL and sometimes even <1.8 μg/dL 4
  • Do not use a normal result to definitively exclude Cushing's syndrome in patients with high clinical suspicion 4

When to Use Alternative Screening

  • For patients with high clinical suspicion, perform 2-3 different screening tests (late-night salivary cortisol, 24-hour urinary free cortisol, and overnight dexamethasone suppression test) rather than relying on a single test 1
  • The 2-day low-dose dexamethasone suppression test (0.5 mg every 6 hours for 48 hours) may be more sensitive but is more cumbersome 3, 1

Alternative Dosing Considerations

  • Some evidence suggests 0.5 mg dexamethasone with a cortisol cut-off of 3 μg/dL provides 99.1% sensitivity and 98.4% specificity for ACTH-dependent Cushing's syndrome 5
  • However, the 1 mg dose remains the standard recommended by major endocrine societies 1

References

Guideline

Dexamethasone Suppression Test Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cortisol Levels and Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Interpretation of 2-Day LDDST Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.